Concepedia

Author

Jeffrey Allebach

Johns Hopkins Medicine

Also Known As

Jeffrey Allebach

4

Publications

1.1K

Citations

3

H-Index

0

Concepts

All Affiliations

Johns Hopkins MedicineJohns Hopkins University
JA

About

Jeffrey Allebach is an author at Johns Hopkins Medicine.

Jeffrey Allebach

×

3

Publications

1.1K

Citations

3

H-Index

YearCitations

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia

B. Douglas Smith, Mark J. Levis, Miloslav Beran,

Blood

2004

622

A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo

Mark J. Levis, Jeffrey Allebach, Kam-Fai Tse,

Blood

2002

469

FLT3/ITD Mutation Signaling Includes Suppression of SHP-1

Peili Chen, Mark J. Levis, Patrick A. Brown,

Journal of Biological Chemistry

2004

41

Page 1